The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activation of the human natural killer cells NK-92 with a lymphocyte-derived cytokine-rich supernatant.
Ioannis F. Voutsas
No relevant relationships to disclose
Pinelopi Samara
No relevant relationships to disclose
Marinos Tsiatas
No relevant relationships to disclose
Margarita Skopeliti
No relevant relationships to disclose
Sotirios Fortis
No relevant relationships to disclose
Aristotelis Bamias
No relevant relationships to disclose
Sylvianna Georgaki
No relevant relationships to disclose
Ourania E. Tsitsilonis
No relevant relationships to disclose